Filing Details
- Accession Number:
- 0001213900-22-040369
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-19 17:30:27
- Reporting Period:
- 2022-07-15
- Accepted Time:
- 2022-07-19 17:30:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
316253 | Enzo Biochem Inc | ENZ | Services-Medical Laboratories (8071) | 132866202 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1913009 | Kara Cannon | C/O Enzo Biochem, Inc. 81 Executive Blvd, Suite 3 Farmingdale NY 11735 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.01 Par Value | Acquisiton | 2022-07-15 | 2,500 | $2.42 | 2,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.01 Par Value | 22,614 | Indirect | 401k |